Literature DB >> 11122562

Glutathione in disease.

M Reid1, F Jahoor.   

Abstract

Altered glutathione metabolism in association with increased oxidative stress has been implicated in the pathogenesis of many diseases. However, whether strategies aimed at restoring glutathione concentration and homeostasis are effective in ameliorating or modifying the natural history of these states is unknown. In this review we discuss the pathogenic role for altered glutathione metabolism in such diseases as protein energy malnutrition, seizures, Alzheimer's disease, Parkinson's disease, sickle cell anaemia, chronic diseases associated with ageing and the infected state. In addition, we discuss the efficacy of glutathione precursors in restoring glutathione homeostasis both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11122562     DOI: 10.1097/00075197-200101000-00012

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  28 in total

1.  Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.

Authors:  I-Y Choi; S-P Lee; D R Denney; S G Lynch
Journal:  Mult Scler       Date:  2010-10-04       Impact factor: 6.312

2.  Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Authors:  Andrea Tamás; Andrea Lubics; István Lengvári; Dóra Reglodi
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Enzymatic defects underlying hereditary glutamate cysteine ligase deficiency are mitigated by association of the catalytic and regulatory subunits.

Authors:  Melanie Neely Willis; Yilin Liu; Ekaterina I Biterova; Melanie A Simpson; Heejeong Kim; Jaekwon Lee; Joseph J Barycki
Journal:  Biochemistry       Date:  2011-06-29       Impact factor: 3.162

4.  Exploring antioxidants.

Authors:  K G Marshall
Journal:  West Indian Med J       Date:  2014-12-18       Impact factor: 0.171

5.  Preparation of N-tBoc L-glutathione dimethyl and di-tert-butyl esters: versatile synthetic building blocks.

Authors:  J R Falck; Bhavani Sangras; Jorge H Capdevila
Journal:  Bioorg Med Chem       Date:  2006-10-25       Impact factor: 3.641

6.  Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism.

Authors:  S Jill James; Stepan Melnyk; George Fuchs; Tyra Reid; Stefanie Jernigan; Oleksandra Pavliv; Amanda Hubanks; David W Gaylor
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

7.  Efficiency of a cysteine-taurine-threonine-serine supplemented parenteral nutrition in an experimental model of acute inflammation.

Authors:  Sylwia Osowska; Jean-Pascal De Bandt; Samira Chaïb; Nathalie Neveux; Marie-Pierre Bérard; Luc Cynober
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

8.  Systems analysis of transcriptional data provides insights into muscle's biological response to botulinum toxin.

Authors:  Kavitha Mukund; Margie Mathewson; Viviane Minamoto; Samuel R Ward; Shankar Subramaniam; Richard L Lieber
Journal:  Muscle Nerve       Date:  2014-03-17       Impact factor: 3.217

9.  Association of the 1q25 Diabetes-Specific Coronary Heart Disease Locus With Alterations of the γ-Glutamyl Cycle and Increased Methylglyoxal Levels in Endothelial Cells.

Authors:  Caterina Pipino; Hetal Shah; Sabrina Prudente; Natalia Di Pietro; Lixia Zeng; Kyoungmin Park; Vincenzo Trischitta; Subramanian Pennathur; Assunta Pandolfi; Alessandro Doria
Journal:  Diabetes       Date:  2020-07-10       Impact factor: 9.461

10.  Stress-dependent regulation of the gene encoding gamma-glutamylcysteine synthetase from the fission yeast.

Authors:  Su-Jung Kim; Eun-Hee Park; Chang-Jin Lim
Journal:  Mol Biol Rep       Date:  2004-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.